Andrew Steele

As part of Prenetics Group, I helped lead the business across all aspects of our digital, operational & strategic delivery across our innovative range of health & diagnostic products for EMEA.

I directly managed the Product, Data, Marketing & Clinical functions for the EMEA side of the business, and our suite of services covered DtC, B2B & B2B2C. Our innovation and scale helped the group achieve a successful IPO listing on the Nasdaq in May 2022.

- Scaled EMEA business from $5m to >$140m annual revenue

- Grew team from 70 to 700+ within 2 years

- Built DtC eCommerce, B2B & Clinical SaaS, White-labelled Enterprise platforms

- Remit across Product, Marketing, Sales, Data, Clinical, Regulatory & Supply

- Products covering iOS, Android, web and locally stored applications

- Achieved multiple UKAS, ISO and CQC standards

- Implemented multiple new revenue streams, services and features

- Built genomics, blood, infectious disease, telehealth, personalised

supplementation, professional marketplace & patient management products

- Achieved Excellent status on Trustpilot & NPS 80+

- Assessed new M&A targets, executed & integrated successful acquisition of a

University of Oxford spinout

- Launched our first hardware device: a point of care molecular device

- Integrated with international network of laboratories across UK Europe, South

Africa and Asia

As an internal secondment, I headed up the team that ran the entire COVID testing and access control program for the Premier League as part of Project Restart and subsequent seasons 20/21 and 21/22, allowing the safe return to play for the world's most watched sports league. An innovative but challenging operation, the testing program created the gold standard for testing in sporting environments, even helping to inform policy decisions, with the eyes of the world watching.

After the successful acquisition of DNAfit by Prenetics, our team became Prenetics EMEA. Incorporating the original product lines, I led the EMEA team in building a new range of groundbreaking personalised health & genomics products

- Launched home blood testing kits with novel pain-free collection device

- Built the world’s first DtC Whole Exome Sequencing DNA test for 500+ traits

- Added cancer risk, pharmacogenomics, ancestry& carrier status

- Built bespoke platforms for Bupa, Aetna International, Generali, HSBC, Prudential

- Delivered digital-first elite sport performance services for international federations

- Partnerships with top-tier brands such as Superdrug, Selfridges, Zurich, Capita

- Sourced and integrated in-house telehealth genetic counselling service